To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Topical tranexamic acid reduces blood loss and transfusion rate following THA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2014

Topical tranexamic acid reduces blood loss and transfusion rate following THA

Vol: 3| Issue: 2| Number:41| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Topical (Intra-Articular) Tranexamic Acid Reduces Blood Loss and Transfusion Rates Following Total Hip Replacement: A Randomized Controlled Trial (TRANX-H)

J Bone Joint Surg Am. 2013 Nov 6;95(21):1969-74

Contributing Authors:
S Alshryda J Mason P Sarda A Nargol N Cooke H Ahmad S Tang R Logishetty M Vaghela L McPartlin AP Hungin

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and sixty-one patients scheduled to receive unilateral primary total hip replacement were randomly assigned into 1 of 2 groups, a tranexamic group or a placebo, to test the effect of topical application of tranexamic acid has on blood loss and transfusion in patients undergoing total hip arthroplasty. The results of the study indicated that topical administration of tranexamic acid was...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue